10-Q Filing

AIM IMMUNOTECH INC. CIK: 946644 Q2 2025

Filing Information

Form Type	10-Q
Accession Number	`0001493152-25-011986`
Period End Date	20250630
Filing Date	20250814
Fiscal Year	2025
Fiscal Period	Q2
XBRL Instance	form10-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 118 Income Statement 132 Cash Flow Statement 142 Stockholders Equity 60

Balance Sheet 118 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$476.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$476.00K	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$359.00K	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$359.00K	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$2.28M	USD	Point-in-time
Marketable investments	`MarketableSecuritiesCurrent`	$2.28M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$199.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$199.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$190.00K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$190.00K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.18M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$4.18M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.02M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.02M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$108.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$108.00K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	350.00M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$89.00K	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$89.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	655,263.00	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	655,263.00	shares	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$496.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$496.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$618.00K	USD	Point-in-time
Right of use asset, net	`OperatingLeaseRightOfUseAsset`	$618.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	764,188.00	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	764,188.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	764,188.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	764,188.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	655,263.00	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	655,263.00	shares	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.59M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.59M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.17M	USD	Point-in-time
Patent and trademark rights, net	`FiniteLivedIntangibleAssetsNet`	$2.17M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.11M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$1.11M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$351.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$351.00K	USD	Point-in-time
Total assets	`Assets`	$8.61M	USD	Point-in-time
Total assets	`Assets`	$8.61M	USD	Point-in-time
Total assets	`Assets`	$4.13M	USD	Point-in-time
Total assets	`Assets`	$4.13M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.38M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$6.38M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.30M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.30M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$573.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$573.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$606.00K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$606.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$233.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$233.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$239.00K	USD	Point-in-time
Current portion of operating lease liability	`OperatingLeaseLiabilityCurrent`	$239.00K	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	$2.29M	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	$2.29M	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	$2.31M	USD	Point-in-time
Current portion of note payable, net	`NotesPayableCurrent`	$2.31M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.54M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$10.39M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$10.39M	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$282.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$282.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$395.00K	USD	Point-in-time
Operating lease liability	`OperatingLeaseLiabilityNoncurrent`	$395.00K	USD	Point-in-time
Total liabilities	`Liabilities`	$10.68M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.68M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.93M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.93M	USD	Point-in-time
Commitments and contingencies (Notes 13 and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 13 and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 13 and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Notes 13 and 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 764,188 and 655,263 as of June 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 764,188 and 655,263 as of June 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 764,188 and 655,263 as of June 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Common Stock, $0.001 par value, authorized shares - 350,000,000; issued and outstanding shares 764,188 and 655,263 as of June 30, 2025 and December 31, 2024, respectively	`CommonStockValue`	$1.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$425.50M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$425.50M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$426.78M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$426.78M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-433.33M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-433.33M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-426.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-426.83M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-3.86M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-3.86M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$10.23M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$10.23M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-6.55M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$-6.55M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$6.10M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$6.10M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$4.83M	USD	Point-in-time
Total stockholders deficit	`StockholdersEquity`	$4.83M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$8.61M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$8.61M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$4.13M	USD	Point-in-time
Total liabilities and stockholders deficit	`LiabilitiesAndStockholdersEquity`	$4.13M	USD	Point-in-time

Income Statement 132 line items

Line Item	Tag	Value	Unit	Period
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$50.00K	USD	1 Quarter
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$50.00K	USD	1 Quarter
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$41.00K	USD	2 Qtrs
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$41.00K	USD	2 Qtrs
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$25.00K	USD	1 Quarter
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$25.00K	USD	1 Quarter
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$90.00K	USD	2 Qtrs
Clinical treatment programs - US	`RevenueFromContractWithCustomerExcludingAssessedTax`	$90.00K	USD	2 Qtrs
Total Revenues	`Revenues`	$25.00K	USD	1 Quarter
Total Revenues	`Revenues`	$25.00K	USD	1 Quarter
Total Revenues	`Revenues`	$41.00K	USD	2 Qtrs
Total Revenues	`Revenues`	$41.00K	USD	2 Qtrs
Total Revenues	`Revenues`	$90.00K	USD	2 Qtrs
Total Revenues	`Revenues`	$90.00K	USD	2 Qtrs
Total Revenues	`Revenues`	$50.00K	USD	1 Quarter
Total Revenues	`Revenues`	$50.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$20.00K	USD	2 Qtrs
Production costs	`ManufacturingCosts`	$20.00K	USD	2 Qtrs
Production costs	`ManufacturingCosts`	$16.00K	USD	2 Qtrs
Production costs	`ManufacturingCosts`	$16.00K	USD	2 Qtrs
Production costs	`ManufacturingCosts`	$8.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$8.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$10.00K	USD	1 Quarter
Production costs	`ManufacturingCosts`	$10.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.10M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$3.10M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.17M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.17M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.25M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.25M	USD	2 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$1.15M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.15M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.49M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.49M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$4.03M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$4.03M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.41M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$6.41M	USD	2 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.59M	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.59M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$6.31M	USD	2 Qtrs
Total Costs and Expenses	`CostsAndExpenses`	$6.31M	USD	2 Qtrs
Total Costs and Expenses	`CostsAndExpenses`	$2.67M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$2.67M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$9.52M	USD	2 Qtrs
Total Costs and Expenses	`CostsAndExpenses`	$9.52M	USD	2 Qtrs
Total Costs and Expenses	`CostsAndExpenses`	$3.74M	USD	1 Quarter
Total Costs and Expenses	`CostsAndExpenses`	$3.74M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-9.43M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-9.43M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.26M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-6.26M	USD	2 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.65M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.65M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.69M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-3.69M	USD	1 Quarter
Gain (Loss) on investments	`GainLossOnInvestments`	$18.00K	USD	2 Qtrs
Gain (Loss) on investments	`GainLossOnInvestments`	$18.00K	USD	2 Qtrs
Gain (Loss) on investments	`GainLossOnInvestments`	$-9.00K	USD	1 Quarter
Gain (Loss) on investments	`GainLossOnInvestments`	$-9.00K	USD	1 Quarter
Gain (Loss) on investments	`GainLossOnInvestments`	$-177.00K	USD	2 Qtrs
Gain (Loss) on investments	`GainLossOnInvestments`	$-177.00K	USD	2 Qtrs
Gain (Loss) on investments	`GainLossOnInvestments`	$-85.00K	USD	1 Quarter
Gain (Loss) on investments	`GainLossOnInvestments`	$-85.00K	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$2.66M	USD	2 Qtrs
Interest and other income	`OtherNonoperatingIncomeExpense`	$2.66M	USD	2 Qtrs
Interest and other income	`OtherNonoperatingIncomeExpense`	$21.00K	USD	2 Qtrs
Interest and other income	`OtherNonoperatingIncomeExpense`	$21.00K	USD	2 Qtrs
Interest and other income	`OtherNonoperatingIncomeExpense`	$2.58M	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$2.58M	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$10.00K	USD	1 Quarter
Interest and other income	`OtherNonoperatingIncomeExpense`	$10.00K	USD	1 Quarter
Interest expense and other finance costs	`InterestExpense`	$273.00K	USD	2 Qtrs
Interest expense and other finance costs	`InterestExpense`	$273.00K	USD	2 Qtrs
Interest expense and other finance costs	`InterestExpense`	$251.00K	USD	2 Qtrs
Interest expense and other finance costs	`InterestExpense`	$251.00K	USD	2 Qtrs
Interest expense and other finance costs	`InterestExpense`	$149.00K	USD	1 Quarter
Interest expense and other finance costs	`InterestExpense`	$149.00K	USD	1 Quarter
Interest expense and other finance costs	`InterestExpense`	$179.00K	USD	1 Quarter
Interest expense and other finance costs	`InterestExpense`	$179.00K	USD	1 Quarter
(Loss) on warrant issuance	`GainLossOnSaleOfDerivatives`	$-458.00K	USD	2 Qtrs
(Loss) on warrant issuance	`GainLossOnSaleOfDerivatives`	$-458.00K	USD	2 Qtrs
(Loss) on warrant issuance	`GainLossOnSaleOfDerivatives`	-	USD	1 Quarter
(Loss) on warrant issuance	`GainLossOnSaleOfDerivatives`	-	USD	1 Quarter
(Loss) on warrant issuance	`GainLossOnSaleOfDerivatives`	$-458.00K	USD	1 Quarter
(Loss) on warrant issuance	`GainLossOnSaleOfDerivatives`	$-458.00K	USD	1 Quarter
(Loss) on warrant issuance	`GainLossOnSaleOfDerivatives`	-	USD	2 Qtrs
(Loss) on warrant issuance	`GainLossOnSaleOfDerivatives`	-	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.71M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-3.71M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-6.50M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-6.50M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-2.79M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-2.79M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-7.65M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-7.65M	USD	2 Qtrs
Net Loss	`NetIncomeLoss`	$-1.84M	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-1.84M	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-3.00	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-3.00	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-8.88	USD	2 Qtrs
Basic loss per share	`EarningsPerShareBasic`	$-8.88	USD	2 Qtrs
Basic loss per share	`EarningsPerShareBasic`	$-15.00	USD	2 Qtrs
Basic loss per share	`EarningsPerShareBasic`	$-15.00	USD	2 Qtrs
Basic loss per share	`EarningsPerShareBasic`	$-3.68	USD	1 Quarter
Basic loss per share	`EarningsPerShareBasic`	$-3.68	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-8.88	USD	2 Qtrs
Diluted loss per share	`EarningsPerShareDiluted`	$-8.88	USD	2 Qtrs
Diluted loss per share	`EarningsPerShareDiluted`	$-3.68	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-3.68	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-15.00	USD	2 Qtrs
Diluted loss per share	`EarningsPerShareDiluted`	$-15.00	USD	2 Qtrs
Diluted loss per share	`EarningsPerShareDiluted`	$-3.00	USD	1 Quarter
Diluted loss per share	`EarningsPerShareDiluted`	$-3.00	USD	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	528,374.00	shares	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	528,374.00	shares	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	759,289.00	shares	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	759,289.00	shares	1 Quarter
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	511,619.00	shares	2 Qtrs
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	511,619.00	shares	2 Qtrs
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	731,650.00	shares	2 Qtrs
Weighted average shares outstanding basic	`WeightedAverageNumberOfSharesOutstandingBasic`	731,650.00	shares	2 Qtrs
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	731,650.00	shares	2 Qtrs
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	731,650.00	shares	2 Qtrs
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	759,289.00	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	759,289.00	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	528,374.00	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	528,374.00	shares	1 Quarter
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	511,619.00	shares	2 Qtrs
Weighted average shares outstanding diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	511,619.00	shares	2 Qtrs

Cash Flow Statement 142 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.71M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.50M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-6.50M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-2.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-2.79M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-7.65M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-7.65M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-1.84M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-1.84M	USD	1 Quarter
Depreciation of property and equipment	`Depreciation`	$18.00K	USD	2 Qtrs
Depreciation of property and equipment	`Depreciation`	$18.00K	USD	2 Qtrs
Depreciation of property and equipment	`Depreciation`	$19.00K	USD	2 Qtrs
Depreciation of property and equipment	`Depreciation`	$19.00K	USD	2 Qtrs
Abandonment and expiration of patents and trademark rights	`ImpairmentOfIntangibleAssetsFinitelived`	-	USD	2 Qtrs
Abandonment and expiration of patents and trademark rights	`ImpairmentOfIntangibleAssetsFinitelived`	-	USD	2 Qtrs
Abandonment and expiration of patents and trademark rights	`ImpairmentOfIntangibleAssetsFinitelived`	$615.00K	USD	2 Qtrs
Abandonment and expiration of patents and trademark rights	`ImpairmentOfIntangibleAssetsFinitelived`	$615.00K	USD	2 Qtrs
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$94.00K	USD	2 Qtrs
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$94.00K	USD	2 Qtrs
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$101.00K	USD	2 Qtrs
Amortization of patent, trademark rights	`AmortizationOfIntangibleAssets`	$101.00K	USD	2 Qtrs
Non-cash lease expense	`OtherNoncashIncomeExpense`	$-150.00K	USD	2 Qtrs
Non-cash lease expense	`OtherNoncashIncomeExpense`	$-150.00K	USD	2 Qtrs
Non-cash lease expense	`OtherNoncashIncomeExpense`	$-81.00K	USD	2 Qtrs
Non-cash lease expense	`OtherNoncashIncomeExpense`	$-81.00K	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$160.00K	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$160.00K	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$60.00K	USD	2 Qtrs
Equity-based compensation	`ShareBasedCompensation`	$60.00K	USD	2 Qtrs
Loss (gain) on sale of marketable investments	`GainLossOnInvestments`	$18.00K	USD	2 Qtrs
Loss (gain) on sale of marketable investments	`GainLossOnInvestments`	$18.00K	USD	2 Qtrs
Loss (gain) on sale of marketable investments	`GainLossOnInvestments`	$-9.00K	USD	1 Quarter
Loss (gain) on sale of marketable investments	`GainLossOnInvestments`	$-9.00K	USD	1 Quarter
Loss (gain) on sale of marketable investments	`GainLossOnInvestments`	$-177.00K	USD	2 Qtrs
Loss (gain) on sale of marketable investments	`GainLossOnInvestments`	$-177.00K	USD	2 Qtrs
Loss (gain) on sale of marketable investments	`GainLossOnInvestments`	$-85.00K	USD	1 Quarter
Loss (gain) on sale of marketable investments	`GainLossOnInvestments`	$-85.00K	USD	1 Quarter
Loss on issuance of warrants	`GainLossOnSaleOfDerivatives`	$-458.00K	USD	2 Qtrs
Loss on issuance of warrants	`GainLossOnSaleOfDerivatives`	$-458.00K	USD	2 Qtrs
Loss on issuance of warrants	`GainLossOnSaleOfDerivatives`	-	USD	1 Quarter
Loss on issuance of warrants	`GainLossOnSaleOfDerivatives`	-	USD	1 Quarter
Loss on issuance of warrants	`GainLossOnSaleOfDerivatives`	$-458.00K	USD	1 Quarter
Loss on issuance of warrants	`GainLossOnSaleOfDerivatives`	$-458.00K	USD	1 Quarter
Loss on issuance of warrants	`GainLossOnSaleOfDerivatives`	-	USD	2 Qtrs
Loss on issuance of warrants	`GainLossOnSaleOfDerivatives`	-	USD	2 Qtrs
Amortization of financial obligation	`AmortizationOfDebtDiscountPremium`	$183.00K	USD	2 Qtrs
Amortization of financial obligation	`AmortizationOfDebtDiscountPremium`	$183.00K	USD	2 Qtrs
Amortization of financial obligation	`AmortizationOfDebtDiscountPremium`	$270.00K	USD	2 Qtrs
Amortization of financial obligation	`AmortizationOfDebtDiscountPremium`	$270.00K	USD	2 Qtrs
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	-	USD	2 Qtrs
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	-	USD	2 Qtrs
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	$-1.18M	USD	2 Qtrs
Funds receivable from New Jersey net operating loss	`IncreaseDecreaseInAccountsReceivable`	$-1.18M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-761.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-761.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$366.00K	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$366.00K	USD	2 Qtrs
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-9.00K	USD	2 Qtrs
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-9.00K	USD	2 Qtrs
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-5.00K	USD	2 Qtrs
Prepaid expenses and other current assets and other non-current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-5.00K	USD	2 Qtrs
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-149.00K	USD	2 Qtrs
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-149.00K	USD	2 Qtrs
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-78.00K	USD	2 Qtrs
Lease liability	`IncreaseDecreaseInOperatingLeaseLiability`	$-78.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-988.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-988.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$914.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$914.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.19M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-1.19M	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-33.00K	USD	2 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-33.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.89M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.89M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.82M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-7.82M	USD	2 Qtrs
Proceeds from sale of marketable investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.03M	USD	2 Qtrs
Proceeds from sale of marketable investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$2.03M	USD	2 Qtrs
Proceeds from sale of marketable investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.10M	USD	2 Qtrs
Proceeds from sale of marketable investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$1.10M	USD	2 Qtrs
Purchase of marketable investments	`PaymentsToAcquireMarketableSecurities`	$158.00K	USD	2 Qtrs
Purchase of marketable investments	`PaymentsToAcquireMarketableSecurities`	$158.00K	USD	2 Qtrs
Purchase of marketable investments	`PaymentsToAcquireMarketableSecurities`	$91.00K	USD	2 Qtrs
Purchase of marketable investments	`PaymentsToAcquireMarketableSecurities`	$91.00K	USD	2 Qtrs
(Purchase) abandonment of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$279.00K	USD	2 Qtrs
(Purchase) abandonment of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$279.00K	USD	2 Qtrs
(Purchase) abandonment of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$283.00K	USD	2 Qtrs
(Purchase) abandonment of patent and trademark rights	`PaymentsToAcquireIntangibleAssets`	$283.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$668.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$668.00K	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.65M	USD	2 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$1.65M	USD	2 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$856.00K	USD	2 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$856.00K	USD	2 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$1.26M	USD	Point-in-time
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$1.26M	USD	Point-in-time
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$765.00K	USD	2 Qtrs
Proceeds from sale of stock, net of issuance costs	`ProceedsFromIssuanceOrSaleOfEquity`	$765.00K	USD	2 Qtrs
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	$2.37M	USD	2 Qtrs
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	$2.37M	USD	2 Qtrs
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	$250.00K	USD	2 Qtrs
Proceeds from note payable, net of issuance costs	`ProceedsFromNotesPayable`	$250.00K	USD	2 Qtrs
Proceeds from issuance of equity warrants	`ProceedsFromIssuanceOfEquityWarrants`	-	USD	2 Qtrs
Proceeds from issuance of equity warrants	`ProceedsFromIssuanceOfEquityWarrants`	-	USD	2 Qtrs
Proceeds from issuance of equity warrants	`ProceedsFromIssuanceOfEquityWarrants`	$2.05M	USD	2 Qtrs
Proceeds from issuance of equity warrants	`ProceedsFromIssuanceOfEquityWarrants`	$2.05M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.01M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.01M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.27M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$5.27M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.23M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.23M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.89M	USD	2 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.89M	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.70M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.70M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$476.00K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$476.00K	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.55M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.55M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.70M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$1.70M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$476.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$476.00K	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.55M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.55M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.44M	USD	Point-in-time
Unrealized gain on marketable investments	`UnrealizedGainOnMarketableInvestments`	$85.00K	USD	2 Qtrs
Unrealized gain on marketable investments	`UnrealizedGainOnMarketableInvestments`	$85.00K	USD	2 Qtrs
Unrealized gain on marketable investments	`UnrealizedGainOnMarketableInvestments`	$42.00K	USD	2 Qtrs
Unrealized gain on marketable investments	`UnrealizedGainOnMarketableInvestments`	$42.00K	USD	2 Qtrs
Repayment of debt obligation with shares	`RepaymentOfDebtObligationWithShares`	-	USD	2 Qtrs
Repayment of debt obligation with shares	`RepaymentOfDebtObligationWithShares`	-	USD	2 Qtrs
Repayment of debt obligation with shares	`RepaymentOfDebtObligationWithShares`	$421.00K	USD	2 Qtrs
Repayment of debt obligation with shares	`RepaymentOfDebtObligationWithShares`	$421.00K	USD	2 Qtrs

Stockholders Equity 60 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$-3.86M	USD	Point-in-time
Balance	`StockholdersEquity`	$-3.86M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$-6.55M	USD	Point-in-time
Balance	`StockholdersEquity`	$-6.55M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.10M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.10M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.83M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.83M	USD	Point-in-time
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$660.00K	USD	1 Quarter
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$660.00K	USD	1 Quarter
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$532.00K	USD	1 Quarter
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$532.00K	USD	1 Quarter
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$105.00K	USD	1 Quarter
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$105.00K	USD	1 Quarter
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$329.00K	USD	1 Quarter
Common stock issuance, net of costs	`StockIssuedDuringPeriodValueNewIssues`	$329.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$80.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$80.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$60.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$60.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$80.00K	USD	1 Quarter
Equity-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$80.00K	USD	1 Quarter
Repayment of Debt with Shares	`StockIssuedDuringPeriodValueOther`	$450.00K	USD	1 Quarter
Repayment of Debt with Shares	`StockIssuedDuringPeriodValueOther`	$450.00K	USD	1 Quarter
Net Comprehensive loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net Comprehensive loss	`NetIncomeLoss`	$-5.82M	USD	1 Quarter
Net Comprehensive loss	`NetIncomeLoss`	$-3.71M	USD	1 Quarter
Net Comprehensive loss	`NetIncomeLoss`	$-3.71M	USD	1 Quarter
Net Comprehensive loss	`NetIncomeLoss`	$-6.50M	USD	2 Qtrs
Net Comprehensive loss	`NetIncomeLoss`	$-6.50M	USD	2 Qtrs
Net Comprehensive loss	`NetIncomeLoss`	$-2.79M	USD	1 Quarter
Net Comprehensive loss	`NetIncomeLoss`	$-2.79M	USD	1 Quarter
Net Comprehensive loss	`NetIncomeLoss`	$-7.65M	USD	2 Qtrs
Net Comprehensive loss	`NetIncomeLoss`	$-7.65M	USD	2 Qtrs
Net Comprehensive loss	`NetIncomeLoss`	$-1.84M	USD	1 Quarter
Net Comprehensive loss	`NetIncomeLoss`	$-1.84M	USD	1 Quarter
Adjustment for fractional shares	`StockIssuedDuringPeriodValueAdjustmentForFractionalShares`	-	USD	1 Quarter
Adjustment for fractional shares	`StockIssuedDuringPeriodValueAdjustmentForFractionalShares`	-	USD	1 Quarter
Cashless Exercise of Warrants	`StockIssuedDuringPeriodValueCashlessExerciseOfWarrants`	-	USD	1 Quarter
Cashless Exercise of Warrants	`StockIssuedDuringPeriodValueCashlessExerciseOfWarrants`	-	USD	1 Quarter
Issuance of Warrants	`StockIssuedDuringPeriodValueIssuanceOfWarrants`	$2.50M	USD	1 Quarter
Issuance of Warrants	`StockIssuedDuringPeriodValueIssuanceOfWarrants`	$2.50M	USD	1 Quarter
Series B preferred shares expired	`StockExpiredDuringPeriodValue`	-	USD	1 Quarter
Series B preferred shares expired	`StockExpiredDuringPeriodValue`	-	USD	1 Quarter
Balance	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$-1.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$-3.86M	USD	Point-in-time
Balance	`StockholdersEquity`	$-3.86M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$10.23M	USD	Point-in-time
Balance	`StockholdersEquity`	$-6.55M	USD	Point-in-time
Balance	`StockholdersEquity`	$-6.55M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.10M	USD	Point-in-time
Balance	`StockholdersEquity`	$6.10M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.83M	USD	Point-in-time
Balance	`StockholdersEquity`	$4.83M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.